×
About 100,290 results

ALLMedicine™ Hepatitis Center

Research & Reviews  34,317 results

Regression of Hepatic Fibrosis and Evolution of Cirrhosis: A Concise Review.
https://doi.org/10.1097/PAP.0000000000000312
Advances in Anatomic Pathology; Khan S, Saxena R

Jul 31st, 2021 - Fibrosis is not a unidirectional, linear process, but a dynamic one resulting from an interplay of fibrogenesis and fibrolysis depending on the extent and severity of a biologic insult, or lack thereof. Regression of fibrosis has been documented b...

Chronic hepatitis B infection with concomitant hepatic steatosis: Current evidence and ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311534
World Journal of Gastroenterology; Shi YW, Yang RX et. al.

Jul 31st, 2021 - With the increasing incidence of obesity and metabolic syndrome worldwide, concomitant nonalcoholic fatty liver disease (NAFLD) in patients with chronic hepatitis B (CHB) has become highly prevalent. The risk of dual etiologies, outcome, and mecha...

Progress and challenges in the comprehensive management of chronic viral hepatitis: Key...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311524
World Journal of Gastroenterology; Higuera-de la Tijera F, Servín-Caamaño A et. al.

Jul 31st, 2021 - Chronic viral hepatitis is a significant health problem throughout the world, which already represents high annual mortality. By 2040, chronic viral hepatitis due to virus B and virus C and their complications cirrhosis and hepatocellular carcinom...

Viral hepatitis update: Progress and perspectives.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311538
World Journal of Gastroenterology; Pisano MB, Giadans CG et. al.

Jul 31st, 2021 - Viral hepatitis, secondary to infection with hepatitis A, B, C, D, and E viruses, are a major public health problem and an important cause of morbidity and mortality. Despite the huge medical advances achieved in recent years, there are still poin...

Prevention of vertical transmission of hepatitis B virus infection.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8311536
World Journal of Gastroenterology; Veronese P, Dodi I et. al.

Jul 31st, 2021 - Hepatitis B virus (HBV) is the leading cause of chronic viral hepatitis. Annually, almost two million children younger than 5 years acquire the infection, mostly through vertical or horizontal transmission in early life. Vertical transmission of H...

see more →

Guidelines  87 results

Screening for Hepatitis B Virus Infection in Adolescents and Adults: Recommendation Sta...
https://www.ncbi.nlm.nih.gov/pubmed/33856166
American Family Physician;

Apr 16th, 2021 - Screening for Hepatitis B Virus Infection in Adolescents and Adults: Recommendation Statement.|2021||blood,diagnosis,prevention & control,blood,diagnosis,prevention & control,

EuroGuiDerm Guideline on the systemic treatment of Psoriasis vulgaris - Part 2: specifi...
https://doi.org/10.1111/jdv.16926
Journal of the European Academy of Dermatology and Venere... Nast A, Smith C et. al.

Feb 7th, 2021 - This evidence- and consensus-based guideline on the treatment of psoriasis vulgaris was developed following the EuroGuiDerm Guideline and Consensus Statement Development Manual. The second part of the guideline provides guidance for specific clini...

Guideline No. 409: Intrauterine Fetal Diagnostic Testing in Women with Chronic Viral In...
https://doi.org/10.1016/j.jogc.2020.09.007
Journal of Obstetrics and Gynaecology Canada : JOGC = Jou... Wilson RD

Dec 15th, 2020 - This revised guideline provides updated information for the care of women with chronic viral infections who require intrauterine fetal diagnostic testing. Women with chronic viral infections who are pregnant or planning a pregnancy. Non-invasive s...

WGO Guidance for the Care of Patients With COVID-19 and Liver Disease.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713641
Journal of Clinical Gastroenterology; Hamid S, Alvares da Silva MR et. al.

Nov 25th, 2020 - Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the least deadly but most infectious coronavirus strain transmitted from wild animals. It may affect many organ systems. Aim of the current guideline is to delineate the effects of SA...

AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor...
https://doi.org/10.1053/j.gastro.2020.08.063
Gastroenterology Dougan M, Wang Y et. al.

Oct 21st, 2020 - Immune checkpoint inhibitors (ICIs) have transformed the treatment landscape for oncology, leading to durable remissions in a subset of patients, but also a broad range of potentially life-threatening inflammatory toxicities, many of which involve...

see more →

Drugs  432 results see all →

Clinicaltrials.gov  1,749 results

Study of Transfusion-Transmitted Infections
https://clinicaltrials.gov/ct2/show/NCT00023023

May 8th, 2020 - Improved viral screening assays and more intensive questioning of donors for high-risk behaviors have resulted in dramatic declines in the rates of transfusion-transmitted hepatitis and AIDS. Nonetheless, there is need for continued vigilance of t...

A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(the Lot Consistency Trial)
https://clinicaltrials.gov/ct2/show/NCT03365921

May 4th, 2020 - This study is a mono-center, randomization, double-blind clinical trial in healthy subjects between 18 to 50. Under the premise of full informed consent, 360 subjects that meet the requirement of clinical trial in the age of 18-50 will be divided ...

HEPLISAV-B Hepatitis B Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's-Tyrosine Kinase Inhibitor (BTK-I)
https://clinicaltrials.gov/ct2/show/NCT03685708

May 1st, 2020 - This study aims to determine the HEPLISAV-B hepatitis B vaccine efficacy in chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) lymphocytic patients that are treatment naive or receiving Bruton s-tyrosine kinase inhibitor (BTK-...

Collection of Biological Samples From Patients With Hepatitis-Associated Aplastic Anemia
https://clinicaltrials.gov/ct2/show/NCT00050115

Apr 29th, 2020 - Our laboratory has a long-standing interest in viruses that affect the bone marrow, especially those causing bone marrow failure. One specific syndrome, hepatitis-associated aplastic anemia, suggests that the same agent is responsible for the seve...

Study of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C Genotypes 1 to 6
https://clinicaltrials.gov/ct2/show/NCT03303599

Apr 24th, 2020 - The interferon- and ribavirin- (RBV) free combination regimen of glecaprevir plus pibrentasvir (GLE/PIB) for the treatment of genotypes 1 to 6 of chronic hepatitis C (CHC) viral infection has been shown to be safe and effective in randomized contr...

see more →

News  3,453 results

New Antiviral Drug Promising Against HBV
https://www.medscape.com/viewarticle/955063

Jul 21st, 2021 - NEW YORK (Reuters Health) - RO7049389, a hepatitis B virus (HBV) core protein allosteric modulator, appears safe and shows antiviral action in patients with chronic HBV infection, according to a small company-funded study. "These results provide p...

HIV: NIDA's Avenir Grant Awarded to Hansel Tookes, MD, MPH, for Tele-Harm Reduction Research
https://www.medscape.com/viewarticle/954836

Jul 15th, 2021 - "There are no interventions that have been shown to be effective in attaining viral suppression in people who inject drugs (PWID)," 2021 HIV/AIDS Research Avenir Award winner Hansel Tookes, MD, infectious disease specialist at the University of Mi...

Latest FDA Pembrolizumab Approval Expands Label to Cutaneous SCCs
https://www.medscape.com/viewarticle/954715

Jul 13th, 2021 - The Food and Drug Administration has approved pembrolizumab (Keytruda) monotherapy for locally advanced cutaneous squamous cell carcinoma (cSCC) that can't be cured by surgery or radiation. The July 6 approval for the programmed death–1 inhibitor ...

Protein Expression May Predict HBV DNA Suppression
https://www.medscape.com/viewarticle/954484

Jul 8th, 2021 - Stopping nucleoside analog therapy in patients with hepatitis B viral (HBV) infections results in sustained viral suppression in only a minority of patients, but a new study suggests there are immune signatures that may serve as predictive biomark...

Worse Survival With Recurrent Autoimmune Hepatitis After Transplant
https://www.medscape.com/viewarticle/954067

Jul 1st, 2021 - Autoimmune hepatitis that recurs following a liver transplant can impair both graft survival and overall survival, results of a large international study showed. Among 736 patients with autoimmune hepatitis who underwent liver transplant and were ...

see more →

Patient Education  78 results see all →